CALLABLE MULTI DEFENDER VONTI - NOVARTIS N/ELI LILLY & CO/PFIZER INC/NOVO-NORDISK B Share Price

Certificat

RMAMHV

CH1315859665

Market Closed - Swiss Exchange 16:20:00 07/05/2024 BST
101 CHF +0.50% Intraday chart for CALLABLE MULTI DEFENDER VONTI - NOVARTIS N/ELI LILLY & CO/PFIZER INC/NOVO-NORDISK B
Current month+1.51%
1 month+1.92%
Date Price Change Volume
07/05/24 101 +0.50% 0
02/05/24 100.5 +1.01% 0

Delayed Quote Swiss Exchange

Last update May 07, 2024 at 04:20 pm

More quotes

Static data

Product typeAktienanleihen
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer Vontobel Vontobel
RMAMHV
ISINCH1315859665
Date issued 23/02/2024
Strike 91.63 CHF
Maturity 23/02/2026 (653 Days)
Parity 0.09 : 1
Emission price 100 CHF
Emission volume N/A
Settlement Beides
Currency CHF

Technical Indicators

Highest since issue 101 CHF
Lowest since issue 97.9 CHF
Spread 16 CHF
Spread %1.58%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
101.8 USD
Average target price
108.4 USD
Spread / Average Target
+6.52%
Consensus
  1. Stock Market
  2. Certificates
  3. RMAMHV Certificat